chr3-132660665-T-TGG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_024818.6(UBA5):c.129_130insGG(p.Ser44GlyfsTer14) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000014 in 1,424,304 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
UBA5
NM_024818.6 frameshift
NM_024818.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.62
Genes affected
UBA5 (HGNC:23230): (ubiquitin like modifier activating enzyme 5) This gene encodes a member of the E1-like ubiquitin-activating enzyme family. This protein activates ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein, via the formation of a high-energy thioester bond. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been identified on chromosome 1. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-132660665-T-TGG is Pathogenic according to our data. Variant chr3-132660665-T-TGG is described in ClinVar as [Pathogenic]. Clinvar id is 985921.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UBA5 | NM_024818.6 | c.129_130insGG | p.Ser44GlyfsTer14 | frameshift_variant | 1/12 | ENST00000356232.10 | |
NPHP3-ACAD11 | NR_037804.1 | n.3996-15775_3996-15774insCC | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UBA5 | ENST00000356232.10 | c.129_130insGG | p.Ser44GlyfsTer14 | frameshift_variant | 1/12 | 1 | NM_024818.6 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000529 AC: 1AN: 189062Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 101204
GnomAD3 exomes
AF:
AC:
1
AN:
189062
Hom.:
AF XY:
AC XY:
0
AN XY:
101204
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1424304Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 704900
GnomAD4 exome
AF:
AC:
2
AN:
1424304
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
704900
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2019 | - - |
UBA5-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 13, 2024 | The UBA5 c.129_130insGG variant is predicted to result in a frameshift and premature protein termination (p.Ser44Glyfs*14). This variant has been reported, along with a missense variant in the same gene, in an individual from a cohort of patients tested by whole genome sequencing for rare diseases (Table S7, Stranneheim et al. 2021. PubMed ID: 33726816). This variant is reported in 0.0012% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in UBA5 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at